The FDA should liberate this birth control pill
Bloomberg covers the unanimous recommendation of a panel of FDA advisors to approve a birth control pill called Opill for over-the-counter use.
Previous
Previous
Over-the-counter birth control access clears final hurdle before approval
Next
Next